Bristol Myers Squibb buys 2seventy Bio for $286M

The latest stories trending on MedCity News.

Editor's Pick

Top Story Bristol Myers Squibb Buys Out Cancer Cell Therapy Partner 2seventy Bio in $286M Deal Multiple myeloma cell therapy Abecma is the lone remaining asset of 2seventy Bio, which spun out from Bluebird Bio in 2021. 2seventy and Bristol Myers Squibb currently share in U.S. commercialization of Abecma. Sponsored Webinar: Using Automation to Streamline Healthcare Practice Workflows and Maximize Staff Effectiveness Presented by Jotform and MedCity News Join us this Thursday as we will discuss how health tech and healthcare practices approach data automation and how they can collaborate effectively. We'll also highlight: Improve time management and maximize healthcare practice productivity Create frictionless appointment scheduling  Improve patient retention and growth The webinar will also offer use cases with clinician and patient-facing examples Register Here.

Featured News

Arboretum Ventures Investor Says Startups Are Adapting to Tough Healthcare Fundraising Environment Charity Tarn, an investor with Arboretum Ventures, will be one of the investor judges for the Pitch Perfect contest at INVEST in Chicago May 20-21. Register today! 4 Prescription Drug Trends that are Top of Mind for One Abarca Exec Abarca Health is paying attention to specialty drugs, AI in healthcare, the impact of obesity-related conditions, and increased government regulations. How Can Startups Navigate the Difficult Funding Environment Many experts — be they venture capitalists or private equity investors — shared their advice with biotech entrepreneurs navigating a tough funding environment. How One AI Company Is Tackling Gun Violence at Hospitals Some healthcare providers have partnered with AI gun detection company ZeroEyes. The company adds its software to hospitals' existing security camera systems to identify a gun before the shooter strikes. Revenue Cycle Automation: 3 Considerations For Optimal ROI  As healthcare leaders look for the low-hanging fruit for AI and automation investments in the revenue cycle, there are three things that should be considered to achieve maximum impact on labor effectiveness. What If Part of the $500 Billion AI Allocation Was Focused On Women's Health? With $500 billion allocated to the Stargate initiative, just imagine what could be done if 10% of that focused on women, who make up 51% of the population.

Video   Telehealth Can Be Easier Than You Think Dave Newman, chief medical officer of virtual care at Sanford Health, thinks that virtual care delivery is often more straightforward than people might think. For rural health systems like his, virtual care isn't just a "nice-to-have" — it's necessary to ensure patients are getting the care they need, he said.

Sponsored How to Improve Employee Benefits While Reducing Insurance Costs Presented by The Difference Card Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost. Learn More

Resources

MedCity Pivot Podcast: Being Clear About Cybersecurity A conversation with David Bardan, the general manager of the healthcare business at Clear, shows how the company is bringing its expertise to counter cybersecurity threats in the healthcare industry. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe